{
  "ticker": "LLY",
  "target_date": "2025-01-28",
  "actual_date": "2025-01-28",
  "collected_at": "2025-12-08T11:19:58.540520",
  "price": {
    "open": 801.26,
    "high": 810.11,
    "low": 794.19,
    "close": 799.0301513671875,
    "volume": 2808800,
    "change_1d_pct": -0.39,
    "change_7d_pct": 6.26,
    "change_30d_pct": 1.13
  },
  "technicals": {
    "rsi_14": 59.07,
    "sma_20": 766.71,
    "sma_50": 772.75,
    "macd": -0.198,
    "macd_signal": -5.676,
    "macd_histogram": 5.478,
    "bb_upper": 811.1,
    "bb_lower": 722.32,
    "price_vs_sma20_pct": 4.22,
    "price_vs_sma50_pct": 3.4,
    "volume_ratio": 0.74
  },
  "fundamentals": {
    "market_cap": 889719881728,
    "pe_ratio": 48.627388,
    "forward_pe": 43.798985,
    "price_to_book": 37.367657,
    "price_to_sales": 14.973458,
    "profit_margin": 30.99,
    "operating_margin": 48.29,
    "roe": 96.47,
    "roa": 17.6,
    "revenue_growth": 53.9,
    "earnings_growth": 480.4,
    "debt_to_equity": 178.516,
    "current_ratio": 1.546,
    "quick_ratio": 0.724,
    "dividend_yield": 59.0,
    "fifty_two_week_high": 1111.99,
    "fifty_two_week_low": 623.78,
    "fifty_day_avg": 911.5326,
    "two_hundred_day_avg": 811.9354,
    "analyst_target": 1056.7045,
    "analyst_recommendation": "buy",
    "num_analysts": 27,
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - General",
    "pct_from_52w_high": -10.75,
    "pct_from_52w_low": 59.11
  },
  "macro": {
    "spy": {
      "price": 599.27,
      "change_1d_pct": 0.86,
      "change_7d_pct": 1.16
    },
    "vix": {
      "level": 16.41,
      "signal": "NORMAL"
    },
    "treasury_10y": {
      "yield_pct": 4.55
    },
    "dollar_index": {
      "level": 107.87
    },
    "gold": {
      "price": 2766.8
    },
    "regime": "BULL_NORMAL"
  },
  "news": [
    {
      "headline": "Pfizer Q4 Earnings Preview: 5 Critical Business Issues To Consider",
      "source": "SeekingAlpha",
      "datetime": 1738077110,
      "summary": "Financial analysis of Pfizer Inc. stock ahead of its earnings release. PFE faces significant headwinds from patent expiries, click for my updated look at the stock.",
      "url": "https://finnhub.io/api/news?id=635f70ede4cab57879dcdf69cd9a4237560cc58ffe2efc18c6c2479b43622855"
    },
    {
      "headline": "Drugmakers Show Restraint on Price Increases in New Trump Era",
      "source": "DowJones",
      "datetime": 1738076400,
      "summary": "Drugmakers Show Restraint on Price Increases in New Trump Era",
      "url": "https://finnhub.io/api/news?id=f17a76ce54722d42e46d57502373ff6b6b7457c0b31bbeec482cfbcfe634f5e6"
    },
    {
      "headline": "NIE: Quarterly Update On An Excellent Equity And Convertible Fund",
      "source": "SeekingAlpha",
      "datetime": 1738062021,
      "summary": "The Virtus Equity & Convertible Income Fund is attracting income-focused investors with its high yield and strong performance. Learn more on NIE CEF here.",
      "url": "https://finnhub.io/api/news?id=21aa62cc6ab5b6962c2285c0e5e217ade81764360204e7beaa6dd32c64cffebd"
    },
    {
      "headline": "Liquidity Up, Markets Up, Liquidity Down, Markets Down",
      "source": "SeekingAlpha",
      "datetime": 1737984600,
      "summary": "Why Kirk Spano thinks there is potential for dislocations in the economy and markets.",
      "url": "https://finnhub.io/api/news?id=a56e17992710f80a83bec8ceaa67347df4dbc4cb2aac362e63993453d59681fc"
    },
    {
      "headline": "Akero Therapeutics Stock Doubles on Liver Data",
      "source": "MarketWatch",
      "datetime": 1737975420,
      "summary": "Akero Therapeutics Stock Doubles on Liver Data",
      "url": "https://finnhub.io/api/news?id=6f677fcfc6d5036fee5e511965c7a78a3b66370f914762185933fc2c5aa97222"
    }
  ],
  "news_count": 5,
  "sec_filings": [
    {
      "form": "4",
      "date": "2025-01-23",
      "description": "xslF345X05/wk-form4_1737667469.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000016/xslF345X05/wk-form4_1737667469.xml"
    },
    {
      "form": "4",
      "date": "2025-01-23",
      "description": "xslF345X05/wk-form4_1737667411.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000014/xslF345X05/wk-form4_1737667411.xml"
    },
    {
      "form": "4",
      "date": "2025-01-23",
      "description": "xslF345X05/wk-form4_1737667361.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000012/xslF345X05/wk-form4_1737667361.xml"
    },
    {
      "form": "4",
      "date": "2025-01-23",
      "description": "xslF345X05/wk-form4_1737667303.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000010/xslF345X05/wk-form4_1737667303.xml"
    },
    {
      "form": "4",
      "date": "2025-01-23",
      "description": "xslF345X05/wk-form4_1737667237.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000008/xslF345X05/wk-form4_1737667237.xml"
    }
  ],
  "sec_filings_count": 5,
  "data_quality": {
    "has_price": true,
    "has_technicals": true,
    "has_fundamentals": true,
    "has_macro": true,
    "has_news": true,
    "has_sec_filings": true
  }
}